Skip to content
Search resources Open menu

Alcohol Blackout

Key Readings: Alcohol, Other Drugs, and Mental Health

Published

Alcohol is seldom the only factor in the cases that reach court. A complainant, an accused person, or a witness may also have used cannabis, taken a prescribed sedative, or been living with posttraumatic stress disorder (PTSD), bipolar disorder, or an anxiety disorder. Each can change how alcohol affects a person, how a drinking episode is remembered and described, and how records about that person should be read. These questions arise for every party, and the research below applies to all of them in the same way.

The readings are grouped by subject and listed oldest first within each group. Each entry gives the full APA citation with its DOI or PubMed Central link, followed by a short summary in our own words of the sample, the method, the main finding, and one limit. Inclusion is not endorsement, and some of the readings point in different directions. Almost all of this research describes groups. A diagnosis, a pattern of drug use, or a statistical association cannot show what one person experienced, remembered, intended, or was capable of on a given night, and a mental-health diagnosis is not a measure of honesty. Entries marked Open access can be read free of charge at the DOI link or through PubMed Central; others may require a library or publisher subscription.

The hub papers that treat these topics in depth are Medications That Add to Alcohol’s Effects; Benzodiazepines, Alcohol, and Memory; Alcohol, Cannabis, and Blackouts; PTSD and Substance Use Disorders; Bipolar Disorder and Substance Use; Anxiety Disorders and Alcohol; and Alcohol-Related Psychosis. Toxicology for drugs other than alcohol, including detection windows, is covered in Counterintuitive Testimony’s Drug-Facilitated Sexual Assault: Toxicology, Detection Limits, and What the Results Can Show.

Alcohol Use Disorder and Other Psychiatric Disorders

Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., & Hasin, D. S. (2015). Epidemiology of DSM-5 alcohol use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry, 72(8), 757–766. https://doi.org/10.1001/jamapsychiatry.2015.0584 — Face-to-face interviews with a nationally representative sample of 36,309 U.S. adults (2012–2013) found 12-month and lifetime alcohol use disorder rates of 13.9% and 29.1%, higher in men than in women. The disorder was associated with other substance use disorders, major depression, bipolar I disorder, and antisocial and borderline personality disorders, and more modestly with several anxiety disorders. The survey is cross-sectional, so it shows co-occurrence rather than which condition came first. Open access.

Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13. https://doi.org/10.1016/j.drugalcdep.2015.05.031 — A meta-analysis of 22 population surveys of randomly selected adults. Alcohol use disorders were associated with higher odds of major depression (pooled odds ratio about 2.4) and of any anxiety disorder (about 2.1), and associations were stronger for dependence than for abuse. Because the samples are community surveys, the figures may not describe clinical or justice-involved populations. Open access.

Castillo-Carniglia, A., Keyes, K. M., Hasin, D. S., & Cerdá, M. (2019). Psychiatric comorbidities in alcohol use disorder. The Lancet Psychiatry, 6(12), 1068–1080. https://doi.org/10.1016/S2215-0366(19)30222-6 — A narrative review of the disorders that most often accompany alcohol use disorder, how they unfold over time, and the explanations offered for the overlap. The authors conclude that the causal pathways differ from disorder to disorder and may include direct effects in both directions, shared genetic and environmental causes, and broader shared traits. It is a review rather than new data, and it leaves the direction of cause unresolved. Open access.

Alcohol and Cannabis Used Together

Mallett, K. A., Turrisi, R., Hultgren, B. A., Sell, N., Reavy, R., & Cleveland, M. (2017). When alcohol is only part of the problem: An event-level analysis of negative consequences related to alcohol and other substance use. Psychology of Addictive Behaviors, 31(3), 307–314. https://doi.org/10.1037/adb0000260 — In 461 college students reporting on 12 weekend nights, nights when alcohol was combined with another substance (nicotine, cannabis, stimulant medication or cocaine) were associated with more negative consequences, such as blackouts, and students who usually combined substances experienced more consequences on nights when they used more substances. Consequences were self-reported and the sample was limited to college students. Open access.

Cummings, C., Beard, C., Habarth, J. M., Weaver, C., & Haas, A. (2019). Is the sum greater than its parts? Variations in substance-related consequences by conjoint alcohol-marijuana use patterns. Journal of Psychoactive Drugs, 51(4), 351–359. https://doi.org/10.1080/02791072.2019.1599473 — An online survey of 610 first-year college students (about half women) compared students who drank only, used alcohol and cannabis on separate occasions, or used both at the same time. Both groups who used the two substances reported more alcohol problems, including blackouts and sexual risk-taking, than those who only drank. The design is cross-sectional and relies on self-report, so it cannot show that combined use caused the problems.

Jackson, K. M., Sokolovsky, A. W., Gunn, R. L., & White, H. R. (2020). Consequences of alcohol and marijuana use among college students: Prevalence rates and attributions to substance-specific versus simultaneous use. Psychology of Addictive Behaviors, 34(2), 370–381. https://doi.org/10.1037/adb0000545 — In 1,390 students aged 18 to 24 at three U.S. campuses (62% women), those who used alcohol and cannabis so that their effects overlapped reported more consequences than alcohol-only users, with the largest differences for impaired driving, blackouts and cognitive problems. Users mostly attributed their consequences to alcohol rather than to the combination. The data are retrospective self-reports. Open access.

Linden-Carmichael, A. N., Van Doren, N., Masters, L. D., & Lanza, S. T. (2020). Simultaneous alcohol and marijuana use in daily life: Implications for level of use, subjective intoxication, and positive and negative consequences. Psychology of Addictive Behaviors, 34(3), 447–453. https://doi.org/10.1037/adb0000556 — Using up to 14 daily reports from 154 young adults (58% women) who used both substances, the authors compared days of simultaneous use with alcohol-only and cannabis-only days. Simultaneous-use days carried more negative consequences, although the amount drunk and the felt level of alcohol intoxication did not differ from alcohol-only days. The sample was small and limited to young adults with recent binge drinking. Open access.

Kloft, L., Otgaar, H., Blokland, A., Monds, L. A., Toennes, S. W., Loftus, E. F., & Ramaekers, J. G. (2020). Cannabis increases susceptibility to false memory. Proceedings of the National Academy of Sciences, 117(9), 4585–4589. https://doi.org/10.1073/pnas.1920162117 — A double-blind, placebo-controlled experiment with 64 healthy volunteers found that THC intoxication increased false recognition on word-list tasks and susceptibility to misinformation in virtual-reality scenarios, tested both while intoxicated and a week later when sober. It is one of the few controlled studies of cannabis and false memory. It tested cannabis alone, not cannabis combined with alcohol. Open access.

Lee, C. M., Calhoun, B. H., Abdallah, D. A., Blayney, J. A., Schultz, N. R., Brunner, M., & Patrick, M. E. (2022). Simultaneous alcohol and marijuana use among young adults: A scoping review of prevalence, patterns, psychosocial correlates, and consequences. Alcohol Research: Current Reviews, 42(1), Article 08. https://doi.org/10.35946/arcr.v42.1.08 — A scoping review of English-language, peer-reviewed studies (2000–2021) of young adults aged 18 to 30 that maps how common simultaneous use is, how it is defined, and what consequences accompany it. A central contribution is separating use with overlapping effects from same-day use, which earlier studies often merged. As a scoping review it describes the literature without pooling effect sizes. Open access.

Stevens, A. K., Boyle, H. K., Sokolovsky, A. W., White, H. R., & Jackson, K. M. (2022). Nuanced relations between simultaneous alcohol and cannabis use motives and negative consequences among college students: The role of multiple product use. Experimental and Clinical Psychopharmacology, 30(5), 593–608. https://doi.org/10.1037/pha0000454 — Over two 28-day bursts of daily reports from 281 college students, reasons for use on simultaneous-use days were linked to different outcomes; using to cope was associated with blackouts on those days. Several of the motive effects ran through using more than one kind of alcoholic drink. The findings are within-person associations from self-report, not causal estimates. Open access.

Fairlie, A. M., Calhoun, B. H., Graupensperger, S., Patrick, M. E., & Lee, C. M. (2023). Daily-level simultaneous alcohol and marijuana use and its associations with alcohol use, marijuana use, and negative consequences in a young adult community sample. Alcohol: Clinical and Experimental Research, 47(9), 1690–1701. https://doi.org/10.1111/acer.15145 — In 409 community young adults (51% women) reporting daily over six two-week bursts, simultaneous-use days involved more drinks, more hours high, and more alcohol-related consequences, even after accounting for the amount drunk. Because it used a community rather than a college sample, it extends the earlier campus findings. Consequences were self-reported the following morning. Open access.

Farrelly, K. N., Amini, T., Coelho, S. G., Fox, N., Dimitrova, N., Hendershot, C. S., & Wardell, J. D. (2025). Proximal antecedents and acute outcomes of simultaneous alcohol and cannabis use: Systematic review of daily- and event-level studies. Alcohol, Clinical and Experimental Research, 49(1), 43–61. https://doi.org/10.1111/acer.15484 — A systematic review of 30 daily- and event-level studies. Simultaneous-use occasions usually involved heavier drinking than alcohol-only occasions, but evidence that they carry more acute harm was mixed, and in several studies the added harm depended on how much alcohol was consumed. It qualifies the group comparisons showing that people who combine the two substances report more problems, since those comparisons do not show what happens on a given occasion. Open access.

Benzodiazepines and Other Medications Combined With Alcohol

Roth, T., Roehrs, T., Wittig, R., & Zorick, F. (1984). Benzodiazepines and memory. British Journal of Clinical Pharmacology, 18(Suppl. 1), 45S–49S. https://doi.org/10.1111/j.1365-2125.1984.tb02581.x — A review describing the anterograde amnesia produced by benzodiazepines, which grows with dose and varies with half-life. The authors proposed that much of the later memory loss reflects disrupted consolidation linked to rapid sleep onset rather than a failure of retrieval. The review is dated and does not address combined use with alcohol. Open access.

Weathermon, R., & Crabb, D. W. (1999). Alcohol and medication interactions. Alcohol Research & Health, 23(1), 40–54. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761694/ — A National Institute on Alcohol Abuse and Alcoholism (NIAAA) review distinguishing pharmacokinetic interactions, in which alcohol changes how a drug is metabolized, from pharmacodynamic interactions, in which alcohol adds to a drug’s effects, especially sedation. It lists classes that interact with alcohol, including benzodiazepines, barbiturates, opioids, antihistamines, antidepressants and muscle relaxants. Some details predate newer medications. Open access.

Mintzer, M. Z., & Griffiths, R. R. (2002). Alcohol and triazolam: Differential effects on memory, psychomotor performance and subjective ratings of effects. Behavioural Pharmacology, 13(8), 653–658. https://doi.org/10.1097/00008877-200212000-00007 — In a double-blind, placebo-controlled laboratory study of 18 healthy volunteers, alcohol and the sedative triazolam were given at doses producing similar psychomotor impairment. Triazolam impaired recognition memory more than alcohol did, while participants rated alcohol’s effects as stronger. The drugs were given separately, not together, and the sample was small.

Griffin, C. E., III, Kaye, A. M., Bueno, F. R., & Kaye, A. D. (2013). Benzodiazepine pharmacology and central nervous system–mediated effects. The Ochsner Journal, 13(2), 214–223. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684331/ — A clinical review of how benzodiazepines act, how individual drugs differ in potency and duration, and their central nervous system effects, including sedation and memory impairment. It notes that older adults, people with organ disease, and people taking other sedating drugs are at greater risk of toxicity. It is a narrative review written for clinicians. Open access.

Chan, L.-N., & Anderson, G. D. (2014). Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol). Clinical Pharmacokinetics, 53(12), 1115–1136. https://doi.org/10.1007/s40262-014-0190-x — A pharmacology review explaining that acute drinking mainly changes how quickly and how completely other drugs are absorbed, with smaller effects on their clearance, and that the most important acute interactions are added effects on the brain, such as sedation and impaired thinking. Long-term heavy drinking is harder to study because liver disease and poor nutrition change drug metabolism. It is a review, not new data.

Breslow, R. A., Dong, C., & White, A. (2015). Prevalence of alcohol-interactive prescription medication use among current drinkers: United States, 1999 to 2010. Alcoholism: Clinical and Experimental Research, 39(2), 371–379. https://doi.org/10.1111/acer.12633 — Using national survey data on 26,657 adults, the authors estimated that about 42% of current drinkers took at least one prescription medication that can interact with alcohol, rising to about 78% of drinkers aged 65 and older; central nervous system drugs were among the most common. The study measured use of both, not whether the two were taken close together. Open access.

PTSD and Substance Use

Calhoun, P. S., Sampson, W. S., Bosworth, H. B., Feldman, M. E., Kirby, A. C., Hertzberg, M. A., Wampler, T. P., Tate-Williams, F., Moore, S. D., & Beckham, J. C. (2000). Drug use and validity of substance use self-reports in veterans seeking help for posttraumatic stress disorder. Journal of Consulting and Clinical Psychology, 68(5), 923–927. https://doi.org/10.1037/0022-006X.68.5.923 — Self-reported drug use by 317 veterans referred for PTSD assessment was compared with same-day urine screens; only 8% had use detected that they had not reported. Among those using drugs, a PTSD diagnosis was associated with more cannabis and depressant use. The study supports the general accuracy of self-report in that clinical setting, which may not carry over to settings where disclosure has legal consequences.

Khoury, L., Tang, Y. L., Bradley, B., Cubells, J. F., & Ressler, K. J. (2010). Substance use, childhood traumatic experience, and posttraumatic stress disorder in an urban civilian population. Depression and Anxiety, 27(12), 1077–1086. https://doi.org/10.1002/da.20751 — Among 587 primary-care and obstetric-gynecology patients at an urban hospital, lifetime dependence rates were high (for example, 39% for alcohol), and substance use, especially cocaine, tracked childhood abuse and current PTSD symptoms. It is one of the few large civilian, non-treatment samples on this question. The design is cross-sectional and the sample is drawn from one highly trauma-exposed setting. Open access.

Debell, F., Fear, N. T., Head, M., Batt-Rawden, S., Greenberg, N., Wessely, S., & Goodwin, L. (2014). A systematic review of the comorbidity between PTSD and alcohol misuse. Social Psychiatry and Psychiatric Epidemiology, 49(9), 1401–1425. https://doi.org/10.1007/s00127-014-0855-7 — A review of 42 studies published from 2007 to 2012, many of them military samples. Among people with PTSD, the rate of alcohol misuse ranged from about 10% to 61%, and associations were strongest for avoidance or numbing and for hyperarousal symptoms. The very wide ranges reflect different populations and measures, which limits any single summary figure.

Kevorkian, S., Bonn-Miller, M. O., Belendiuk, K., Carney, D. M., Roberson-Nay, R., & Berenz, E. C. (2015). Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample. Psychology of Addictive Behaviors, 29(3), 633–638. https://doi.org/10.1037/adb0000110 — In 34,396 adults from a national U.S. survey (52% women), trauma exposure was associated with having used cannabis, and among trauma-exposed adults PTSD was associated with cannabis use disorder. The odds ratios were modest. The data are cross-sectional, so the order in which trauma, PTSD and cannabis use arose cannot be determined. Open access.

Manhapra, A., Stefanovics, E., & Rosenheck, R. (2015). Treatment outcomes for veterans with PTSD and substance use: Impact of specific substances and achievement of abstinence. Drug and Alcohol Dependence, 156, 70–77. https://doi.org/10.1016/j.drugalcdep.2015.08.036 — Among 22,948 veterans admitted to specialized PTSD programs, those using alcohol, cannabis, opioids, sedatives, cocaine or several substances improved on PTSD symptoms, violent behavior and suicidality about as much as those using none, and abstinence after discharge was associated with greater improvement in every group. Substance use was self-reported, and the program-evaluation design lacked a randomized comparison. Open access.

Steenkamp, M. M., Blessing, E. M., Galatzer-Levy, I. R., Hollahan, L. C., & Anderson, W. T. (2017). Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review. Depression and Anxiety, 34(3), 207–216. https://doi.org/10.1002/da.22596 — A review of animal and human research on cannabinoids for PTSD. The authors found the treatment studies too limited and too weak to support conclusions, with some promise for nightmares and sleep, and noted stronger evidence linking cannabis to psychosis and substance misuse. Animal findings are reported as such and may not translate to people. Open access.

Smith, N. D. L., & Cottler, L. B. (2018). The epidemiology of post-traumatic stress disorder and alcohol use disorder. Alcohol Research: Current Reviews, 39(2), 113–120. https://doi.org/10.35946/arcr.v39.2.02 — An NIAAA review of four decades of research showing that people with PTSD drink more and develop alcohol use disorder more often than people without it. The authors describe evidence for both directions of influence, drinking to relieve symptoms and heavy use raising the risk of trauma exposure, and note that no single symptom cluster has been settled as the key link. It is a narrative review. Open access.

Allan, N. P., Ashrafioun, L., Kolnogorova, K., Raines, A. M., Hoge, C. W., & Stecker, T. (2019). Interactive effects of PTSD and substance use on suicidal ideation and behavior in military personnel: Increased risk from marijuana use. Depression and Anxiety, 36(11), 1072–1079. https://doi.org/10.1002/da.22954 — Following 545 current and former service members at risk for suicide (88% men) for a year by telephone, the authors found that, at high levels of PTSD symptoms, more days of cannabis use predicted worsening PTSD symptoms and suicidal behavior; heavy drinking and opioid use were also measured. The sample was selected for suicide risk and was mostly male, which limits generalization.

Luciano, M. T., Acuff, S. F., Olin, C. C., Lewin, R. K., Strickland, J. C., McDevitt-Murphy, M. E., & Murphy, J. G. (2022). Posttraumatic stress disorder, drinking to cope, and harmful alcohol use: A multivariate meta-analysis of the self-medication hypothesis. Journal of Psychopathology and Clinical Science, 131(5), 447–456. https://doi.org/10.1037/abn0000764 — A meta-analysis of 34 studies (about 15,000 participants) testing whether drinking to cope explains the link between PTSD symptoms and harmful drinking. Coping motives accounted for most of that link, consistent with the self-medication account, although results varied with measurement and design and there was evidence of publication bias. Most included studies were cross-sectional. Open access.

Hien, D. A., Morgan-López, A. A., Saavedra, L. M., Ruglass, L. M., Ye, A., López-Castro, T., Fitzpatrick, S., Killeen, T. K., Norman, S. B., Ebrahimi, C. T., & Back, S. E. (2023). Project Harmony: A meta-analysis with individual patient data on behavioral and pharmacologic trials for comorbid posttraumatic stress and alcohol or other drug use disorders. American Journal of Psychiatry, 180(2), 155–166. https://doi.org/10.1176/appi.ajp.22010071 — Pooling individual records from 36 trials (4,046 adults), the authors found that combining trauma-focused therapy with medication for the substance use disorder produced the largest improvements in both PTSD and alcohol-use severity at the end of treatment compared with usual care, and most treatments were followed by some improvement. It shows that the two conditions can be treated together. Differences among trials in populations and measures required statistical harmonization, which adds uncertainty. Open access.

Pozzolo Pedro, M. O., Pozzolo Pedro, M., Monteiro, G. Z., Klaumann, V. C., Gonçalves, P. D., Martins, S. S., & Castaldelli-Maia, J. M. (2026). How common is alcohol use disorder in posttraumatic stress disorder? A systematic review, meta-analysis, and moderator analysis. The American Journal on Addictions, 35(6), 727–738. https://doi.org/10.1111/ajad.70200 — A meta-analysis of 20 studies (about 185,000 adults with PTSD) estimated lifetime alcohol use disorder at about 36%, with higher rates in clinical, inpatient and veteran samples. Too few studies of current disorder were available to pool. Heterogeneity across studies was very high, so the pooled figure is a rough average rather than a precise rate. Open access.

Bipolar Disorder and Substance Use

Strakowski, S. M., & DelBello, M. P. (2000). The co-occurrence of bipolar and substance use disorders. Clinical Psychology Review, 20(2), 191–206. https://doi.org/10.1016/S0272-7358(99)00025-2 — A review of four explanations for why bipolar and substance use disorders occur together: substance use as a symptom of bipolar illness, as self-medication, as a cause of bipolar illness, or as a product of shared risk factors. The authors concluded that no single explanation fits every case and that each probably contributes. It frames the question well but predates most longitudinal work.

Cassidy, F., Ahearn, E. P., & Carroll, B. J. (2001). Substance abuse in bipolar disorder. Bipolar Disorders, 3(4), 181–188. https://doi.org/10.1034/j.1399-5618.2001.30403.x — Among 392 inpatients admitted for mania or a mixed episode, lifetime alcohol abuse was 48.5% and drug abuse 43.9%; men had higher rates than women, and a substance abuse history was associated with more hospitalizations. The sample was limited to hospitalized patients at one center, who may differ from outpatients and community cases.

Grunebaum, M. F., Galfalvy, H. C., Nichols, C. M., Caldeira, N. A., Sher, L., Dervic, K., Burke, A. K., Mann, J. J., & Oquendo, M. A. (2006). Aggression and substance abuse in bipolar disorder. Bipolar Disorders, 8(5, Pt. 1), 496–502. https://doi.org/10.1111/j.1399-5618.2006.00349.x — In 146 people with bipolar disorder, a lifetime substance use disorder was associated with male sex, impulsive-aggressive traits and earlier onset of mood symptoms, and the first mood episode usually preceded the substance problem. The retrospective design relies on recalled timing, and the finding concerns traits measured in a group, not aggression by any individual.

Goldberg, J. F., Garno, J. L., Callahan, A. M., Kearns, D. L., Kerner, B., & Ackerman, S. H. (2008). Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability. The Journal of Clinical Psychiatry, 69(11), 1751–1757. https://doi.org/10.4088/JCP.v69n1110 — A record review of 85 dual-diagnosis inpatients found that only a third of those with a suspected bipolar diagnosis met formal criteria when mood episodes were assessed during periods of abstinence. It is a caution that mood swings during active substance use can be mistaken for bipolar disorder. The sample came from one private inpatient unit.

Hunt, G. E., Malhi, G. S., Cleary, M., Lai, H. M. X., & Sitharthan, T. (2016). Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990–2015: Systematic review and meta-analysis. Journal of Affective Disorders, 206, 331–349. https://doi.org/10.1016/j.jad.2016.07.011 — A meta-analysis of studies of people in treatment for bipolar disorder found alcohol use disorder in about 42%, cannabis use disorder in about 20%, and other illicit drug use disorders in about 17%. Men had higher lifetime risk than women, and co-occurrence was associated with earlier onset and somewhat more hospitalizations. Treatment samples may overstate rates found in the community. Open access.

Messer, T., Lammers, G., Müller-Siecheneder, F., Schmidt, R. F., & Latifi, S. (2017). Substance abuse in patients with bipolar disorder: A systematic review and meta-analysis. Psychiatry Research, 253, 338–350. https://doi.org/10.1016/j.psychres.2017.02.067 — A meta-analysis of risk factors for substance use disorders among adults with bipolar disorder found associations with male sex (odds ratio about 2.2), more manic episodes, and a history of suicidality, but not with age, bipolar subtype, or co-occurring anxiety. The included studies varied considerably in design and definitions.

Grunze, H., Schaefer, M., Scherk, H., Born, C., & Preuss, U. W. (2021). Comorbid bipolar and alcohol use disorder—A therapeutic challenge. Frontiers in Psychiatry, 12, Article 660432. https://doi.org/10.3389/fpsyt.2021.660432 — A clinical review placing lifetime alcohol use disorder among people with bipolar disorder at roughly 40% to 70%, more often in men, and describing how each condition worsens the course of the other. It favors integrated treatment of both conditions in one setting. It is a narrative review, and its prevalence range is broad. Open access.

Anxiety Disorders and Alcohol

Hobbs, J. D. J., Kushner, M. G., Lee, S. S., Reardon, S. M., & Maurer, E. W. (2011). Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence. The American Journal on Addictions, 20(4), 319–329. https://doi.org/10.1111/j.1521-0391.2011.00140.x — A meta-analysis of 15 randomized trials found that adding treatment for anxiety or depression to alcohol treatment produced small gains in those symptoms and smaller gains in drinking outcomes. The authors note that about half of people treated for alcohol use disorder also have an anxiety or depressive disorder. The number of trials was small. Open access.

Smith, J. P., & Randall, C. L. (2012). Anxiety and alcohol use disorders: Comorbidity and treatment considerations. Alcohol Research: Current Reviews, 34(4), 414–431. https://doi.org/10.35946/arcr.v34.4.06 — An NIAAA review describing how anxiety disorders and alcohol use disorders develop together and how treatments for each may need to be adapted, sequenced, or combined when both are present. It is a clinical overview rather than a systematic review. Open access.

Schry, A. R., & White, S. W. (2013). Understanding the relationship between social anxiety and alcohol use in college students: A meta-analysis. Addictive Behaviors, 38(11), 2690–2706. https://doi.org/10.1016/j.addbeh.2013.06.014 — A meta-analysis of college samples found that socially anxious students drank somewhat less on average but reported more alcohol-related problems and more drinking to cope or to fit in. The findings show that heavier drinking does not account for all of the added risk. Results varied with how samples were recruited.

Gimeno, C., Dorado, M. L., Roncero, C., Szerman, N., Vega, P., Balanzá-Martínez, V., & Alvarez, F. J. (2017). Treatment of comorbid alcohol dependence and anxiety disorder: Review of the scientific evidence and recommendations for treatment. Frontiers in Psychiatry, 8, Article 173. https://doi.org/10.3389/fpsyt.2017.00173 — A review of trials, meta-analyses and guidelines on medication and psychotherapy for people with both disorders, which notes that some antidepressants should be used cautiously while a person is still drinking. It offers treatment recommendations rather than forensic conclusions. Open access.

Alcohol- and Substance-Induced Psychosis

Jordaan, G. P., & Emsley, R. (2014). Alcohol-induced psychotic disorder: A review. Metabolic Brain Disease, 29(2), 231–243. https://doi.org/10.1007/s11011-013-9457-4 — A review of the limited research on psychosis caused by alcohol. The authors report that it can be distinguished clinically from withdrawal delirium and from schizophrenia, that it carries high rates of other psychiatric disorders, readmission and suicidal behavior, and that its outlook is less favorable than once thought, though usually good when abstinence is maintained. Few prospective studies were available.

Starzer, M. S. K., Nordentoft, M., & Hjorthøj, C. (2018). Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis. American Journal of Psychiatry, 175(4), 343–350. https://doi.org/10.1176/appi.ajp.2017.17020223 — Using Danish national registers, the authors followed 6,788 people diagnosed with a substance-induced psychosis between 1994 and 2014; about 32% were later diagnosed with schizophrenia or bipolar disorder, with the highest rate (about 47%) after cannabis-induced psychosis. It shows that a substance-induced label can be provisional. The study relied on diagnoses recorded in the registers rather than on research interviews. Open access.

This paper is for educational purposes only and is not legal advice. The author is a psychologist, not an attorney; summaries of law are general and must be verified against current authority or with a licensed attorney.

Related topic papers: Medications That Add to Alcohol’s Effects · Benzodiazepines, Alcohol, and Memory · Alcohol, Cannabis, and Blackouts · PTSD and Substance Use Disorders · Bipolar Disorder and Substance Use · Anxiety Disorders and Alcohol

Related topics from Arizona Forensic Services: Counterintuitive Testimony: Key Readings on Counterintuitive Behavior Testimony · Reading Research Claims: A Guide for Attorneys